Brevetti EPO No.3830119 2025.11.12
Brevetti EPO
(10) Registration Number and Date
2026000072 2026.02.17
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2026/000072 2019.07.31
(40) Publication Number and Date
SM /T/2026/000072 2026.02.17
(30) Priority Details
EP 18306050
2018.08.01
EP 19153992
2019.01.28
(71/73) Applicant
(IT) IMCHECK THERAPEUTICS : 31 Chemin Joseph Aiguier, 13009 Marseille 9e Arrondissement, FR
(IT) AIX-MARSEILLE UNIVERSITÉ : 58 Boulevard Charles Livon, 13284 Marseille Cedex 07, FR
(IT) CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS - ETABLISSEMENT PUBLIC, SCIENTIFIQUE ETTECHNOLOGIQUE (EPST) : 3 rue Michel Ange, 75018 Paris, FR
(72) Inventor
(IT) DE GASSART, Aude : c/o Imcheck Therapeutics Campus du CNRS, 13009 Marseille, FR
(IT) TRUNEH, Alemseged : 93 Atkinson Lane, Sudbury, Massachusetts 01776, US
(IT) PASERO, Christine : 151 chemin de la Colline St Joseph Bâtiment B, 13009 Marseille, FR
(74) Representative Name
(IT) MONTEBELLI, Marco : Piazza E. Enriquez, 22c, 47891 Dogana RSM, SM
(54) Title
(IT) ANTICORPI ANTI-BTN3A E LORO USO NEL TRATTAMENTO DI CANCRO O DISTURBI INFETTIVI
(EN) ANTI-BTN3A ANTIBODIES AND THEIR USE IN TREATING CANCER OR INFECTIOUS DISORDERS
(57) Abstract
(58) Citations